Abstract

In the treatment of patients with obstructive coronary artery disease, myocardial revascularization remains the most important goal as evidence exists that this treatment strategy, even more than prescription of drugs, effectively improves symptoms and prognosis. Besides the classic approach of coronary bypass surgery (CABG), percutaneous coronary intervention (PCI) is at the operators disposal since 1978, (Gruentzig 1978). With the rapidly evolving technology and expanding indications, PCI first rivaled but now has surpassed CABG as treatment of first choice. The development of PCI has stimulated other innovations such as the introduction of the so-called stent. Dotter and his colleagues were the first to employ the word stent in their description of a technique for the nonsurgical endarterial placement of a tubular coiled wire graft in the peripheral arteries of dogs.

, , , , ,
P.W.J.C. Serruys (Patrick) , G.J. Tangelder
Erasmus University Rotterdam
Financial support by the Netherlands Heart Foundation and the Onze Lieve Vrouwe Gasthuis for the publication of this thesis is gratefully acknowledged. The printing of this thesis was financial supported by: Astra Zeneca, Bayer,Boston Scientific, Bristol-Myers Squibb, Cardialysis, Cordis Corporation, a Johnson & Johnson Company, Eli Lilly, Jomed, Merck Sharpe & Dohme, Pfizer, and Sanofi-Synthelabo.
hdl.handle.net/1765/51162
Erasmus MC: University Medical Center Rotterdam

IJsselmuiden, A. (2003, January 8). Treatment strategies in interventional cardiology. Retrieved from http://hdl.handle.net/1765/51162